Paper Details

  1. Home
  2. Paper Details

[Laboratory and clinical studies on aztreonam in the pediatric field].

Author: HosodaT, MasudaM, MiyaoM

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Aztreonam (AZT), a new monobactam antibiotic, was effective in 80% of 10 pediatric patients with various infections, particularly against Gram-negative bacteria, without any observed side effects.
Paper Details　
Original Abstract of the Article :
Laboratory and clinical studies were performed as follows on aztreonam (AZT), a new monobactam antibiotic. Pharmacokinetics Serum concentrations of AZT were measured in 1 patient given 20 mg/kg by intravenous bolus injection. The peak concentration was 100 micrograms/ml at 15 minutes, and T 1/2 was ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/4094067

データ提供：米国国立医学図書館（NLM）

Aztreonam: A New Oasis in the Desert of Pediatric Infections

This research explores the potential of aztreonam (AZT), a new monobactam antibiotic, for treating pediatric infections. It’s like discovering a new spring in the desert, offering hope for a thirsty traveler. The researchers conducted laboratory and clinical studies to evaluate AZT's pharmacokinetics and efficacy in children. The results show that AZT was well-tolerated and effective in treating infections caused by Gram-negative bacteria. This discovery is like finding a refreshing oasis in the vast desert of pediatric infections.

The Desert of Pediatric Infections: Navigating the Challenges

The study highlights the promise of AZT as a valuable addition to the pediatric physician’s arsenal. It’s like finding a new tool in the desert that can help navigate the challenges of treating children with bacterial infections. The research suggests that AZT can be a reliable option for combating infections in children, offering a new path to health in a landscape often filled with uncertainty.

Aztreonam: A New Spring in the Desert

This research provides hope for children battling bacterial infections. AZT offers a new avenue for treating these infections and potentially improving the health and well-being of young patients. It’s like a new spring emerging in the desert, bringing life and vitality to a parched land.

Dr. Camel's Conclusion

This research presents AZT as a promising new antibiotic for pediatric infections. It’s like finding a new spring in the desert, offering hope for a thirsty traveler. The research suggests that AZT could be a valuable tool for treating children with infections, bringing relief and a new lease on life.

Date :
  1. Date Completed 1986-04-21
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

4094067

DOI: Digital Object Identifier

4094067

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.